Skip to main content
. 2022 Jan 31;12(5):2028–2040. doi: 10.7150/thno.68563

Figure 1.

Figure 1

Schematic representation of FCP-Tph/HA for chemo-photodynamic therapy in tumors. A) Preparation of FCP-Tph/HA by a coordination-driven self-assembly. B) The molecular mechanism of FCP-Tph/HA for synergistic chemo-photodynamic therapy in tumor treatments. C) Active targeting delivery of FCP-Tph/HA by the specific binding of HA and CD44.